Cancer drugmaker Parabilis aims to raise $475 million in a US IPO, testing biotech investor sentiment as the company progresses its oncology…
Anthropic, the AI startup, picks Morgan Stanley and Goldman Sachs to lead its IPO, signaling strong demand for AI listings and potential…
Applied Aerospace shares climbed 3.75% in their market debut, reflecting strong demand for the $650 million US IPO and bolstering sentiment in…
A powerful IPO revival, led by SpaceX’s record-breaking plans, lifts equity indices and reflects surging market confidence.
JPMorgan strategist Olga Lipikhina says an earnings supercycle will power US stocks higher, signaling long-term bullish sentiment for the S&P 500 and…
Applied Aerospace & Defense's $650 million US IPO highlights strong investor appetite for defense stocks amid elevated geopolitical tensions and military spending.
SpaceX moves closer to an initial public offering, with sources indicating terms may be set this week, marking a milestone for the…
Anthropic's massive IPO filing, expected to rank among the largest tech debuts, underscores surging investor demand for generative AI and could lift…
ERock's $642 million IPO filing aims to capitalize on robust power demand, offering a fresh gauge of investor sentiment toward utility stocks.
The US government’s appeal against a broad tariff refund order sustains trade policy uncertainty, potentially weighing on the dollar and equities as…
Strong corporate earnings reduce recession fears, boosting equity market outlook according to HSBC strategist Max Kettner.
Apotex Health's IPO on the TSX signals a thaw in Canadian public markets, potentially reviving equity issuance and investor sentiment.